ONCO


Clinical and biochemical diagnostic laboratory

The laboratory carries out all types of necessary clinical and laboratory tests: detailed and biochemical blood tests, coagulogram, general urine analysis, Zimnitsky test, stool test for parasites, urine for Bays-Jones proteins (myeloma disease), LDH (melanoma, lymphomas).

There is a bacteriological laboratory. Over the past 2 years, enzyme immunoassay methods have been introduced and are being used to detect HSA, ƒntiнcV, HIV in the blood, determine the level of tumor markers in the blood (Ca-125, Ca 19-9, Ca 15-3, hCG, CEA, AFP), hormones (TSH, T4, T3, progesterone, estrogen fractions, testosterone, FSH, LH, prolactin) in the blood, and detect T‘Rcн infections (ureaplasmosis, mycoplasmosis, gonorrhea, trichomoniasis, chlamydia, etc.) in the blood. Alpha-fetoprotein diagnostics (AFP), monitoring the course and effectiveness of therapy for primary hepatocellular carcinoma (HCC) and germ cell tumors, and diagnostics of fetal malformations are also performed. The laboratory determines CA-125 (carbohydrate tumor marker antigen) for early diagnostics, treatment monitoring and detection of relapses of serous ovarian cancer. CA 15-3 (carbohydrate tumor marker antigen in combination with CEA) is determined for diagnostics, monitoring of the course and evaluation of the effectiveness of breast cancer therapy. CA 19-9 (carbohydrate tumor marker antigen) is determined for diagnostics and treatment monitoring of colorectal tumors, gallbladder cancer and pancreatic cancer. Prostate-specific antigen (PSA) is determined for early diagnostics and monitoring of the effectiveness of prostate cancer treatment.

Carcinoembryonic antigen (CEA) is determined for diagnostics of stomach, colon and rectal cancer, monitoring the effectiveness of treatment of patients with gastrointestinal tract tumors, detection of breast and lung cancer. Human chorionic gonadotropin (hCG) is determined for the diagnosis of physiological and pathological pregnancies, hydatidiform mole, genetic and oncological diseases of the fetus.